PK Study of Dapagliflozin in Pediatric Subjects with T2DM

Trial Identifier: MB102-091
Sponsor: AstraZeneca
Collaborator:
Bristol-Myers Squibb
NCTID:: NCT01525238
Start Date: July 2012
Primary Completion Date: September 2014
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Mexico, Jalisco Guadalajara, Jalisco, Mexico, 44150
Mexico, Nuevo Leon Monterrey, Nuevo Leon, Mexico, 64460
Mexico, Veracruz Veracruz, Mexico, 91910
USA, AL Birmingham, AL, USA, 35233
USA, CA Los Angeles, CA, USA, 90036
USA, FL Orlando, FL, USA, 32827
USA, GA Atlanta, GA, USA, 30322
USA, KY Louisville, KY, USA, 40202
USA, LA Shreveport, LA, USA, 71103
USA, MO Kansas City, MO, USA, 64108
USA, NY Buffalo, NY, USA, 14222
USA, OH Toledo, OH, USA, 43606
USA, OH Toledo, OH, USA, 43608
USA, PA Philadelphia, PA, USA, 19104
USA, PA Pittsburgh, PA, USA, 15224
USA, TN Memphis, TN, USA, 38103
USA, TX San Antonio, TX, USA, 78207